Pacira BioSciences - 53 Year Dividend History | PCRX
Historical dividend payout and yield for Pacira BioSciences (PCRX) since 1971. The current TTM dividend payout for Pacira BioSciences (PCRX) as of April 18, 2024 is $0.00. The current dividend yield for Pacira BioSciences as of April 18, 2024 is 0.00%.
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Drug Manufacturing |
$1.214B |
$0.675B |
|
Pacira BioSciences, Inc. is a specialty pharmaceutical company focused on the development, commercialization and manufacture of proprietary pharmaceutical products primarily for use in hospitals and ambulatory surgery centers. These products are developed using the company's proprietary DepoFoam drug delivery technology. Pacira changed its name to Pacira BioSciences following the acquisition of MyoScience. Exparel, the company's flagship product, is a liposome injection of bupivacaine, which is indicated for single-dose administration into the surgical site to produce postsurgical analgesia. The company signed a licensing agreement with Aratana for the development and commercialization of Exparel for animal health indications.
|
| Stock Name |
Country |
Market Cap |
PE Ratio |
